Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Naruge

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Supportive management of cisplatin and gemcitabine combination therapy for advanced biliary tract cancer]Daisuke Naruge, Junji Furuse
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 11, 2015
[Systemic chemotherapy for unresectable pancreatic cancer]Daisuke Naruge, Fumio Nagashima, Junji Furuse
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 14, 2019
[Investigation of the Cases of Deaths at Home after Discharge from Palliative Care Unit]Hiromi Sano, Tomoaki Takasugi, Daisuke Naruge, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2015
[Chemoradiotherapy for Locally Advanced Pancreatic Cancer]Naohiro Okano, Kirio Kawai, Daisuke Naruge, et al.
Palliative Medicine Reports|July 5, 2021
Tramadol/Acetaminophen Combination Tablets in Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Single-Arm Phase II StudyDaisuke Naruge, Fumio Nagashima, Kirio Kawai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 9, 2012
[The development of chemotherapy to unresectable advanced biliary tract cancer]Shiho Arima, Daisuke Naruge, Akiyoshi Kasuga, et al.
Investigational New Drugs|March 22, 2020
First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumorsNaohiro Okano, Daisuke Naruge, Kirio Kawai, et al.
Anticancer Research|July 3, 2017
Axitinib for Gemcitabine-refractory Advanced Biliary Tract Cancer: Report of 5 CasesNaohiro Okano, Akiyoshi Kasuga, Kirio Kawai, et al.
Cancer Chemotherapy and Pharmacology|December 31, 2014
Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refractory advanced pancreatic cancer: inflammation-based prognostic score predicts survivalAkiyoshi Kasuga, Naohiro Okano, Daisuke Naruge, et al.
Anticancer Research|March 2, 2018
The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract CancerNaohiro Okano, Akiyoshi Kasuga, Kirio Kawai, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Supportive management of cisplatin and gemcitabine combination therapy for advanced biliary tract cancer]Daisuke Naruge, Junji Furuse
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 11, 2015
[Systemic chemotherapy for unresectable pancreatic cancer]Daisuke Naruge, Fumio Nagashima, Junji Furuse
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 14, 2019
[Investigation of the Cases of Deaths at Home after Discharge from Palliative Care Unit]Hiromi Sano, Tomoaki Takasugi, Daisuke Naruge, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 23, 2015
[Chemoradiotherapy for Locally Advanced Pancreatic Cancer]Naohiro Okano, Kirio Kawai, Daisuke Naruge, et al.
Palliative Medicine Reports|July 5, 2021
Tramadol/Acetaminophen Combination Tablets in Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Single-Arm Phase II StudyDaisuke Naruge, Fumio Nagashima, Kirio Kawai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 9, 2012
[The development of chemotherapy to unresectable advanced biliary tract cancer]Shiho Arima, Daisuke Naruge, Akiyoshi Kasuga, et al.
Investigational New Drugs|March 22, 2020
First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumorsNaohiro Okano, Daisuke Naruge, Kirio Kawai, et al.
Anticancer Research|July 3, 2017
Axitinib for Gemcitabine-refractory Advanced Biliary Tract Cancer: Report of 5 CasesNaohiro Okano, Akiyoshi Kasuga, Kirio Kawai, et al.
Cancer Chemotherapy and Pharmacology|December 31, 2014
Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refractory advanced pancreatic cancer: inflammation-based prognostic score predicts survivalAkiyoshi Kasuga, Naohiro Okano, Daisuke Naruge, et al.
Anticancer Research|March 2, 2018
The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract CancerNaohiro Okano, Akiyoshi Kasuga, Kirio Kawai, et al.
Pageof 2